Lithium Versus Other Mood Stabilizing Medications in a Longitudinal Study of Bipolar Youth

Lithium (LI) is the mainstay for bipolar disorder (BD) treatment in adults, but evidence in youth is limited. We used data from the Course and Outcome of Bipolar Youth (COBY) study to assess whether LI vs. other mood stabilizing medication (OMS) was associated with improved outcomes, including mood symptoms and suicidality.

Source: Journal of the American Academy of Child and Adolescent Psychiatry - July 28, 2019 Category: Psychiatry Authors: Danella M. Hafeman, Brian Rooks, John Merranko, Fangzi Liao, Mary Kay Gill, Tina R. Goldstein, Rasim Diler, Neal Ryan, Benjamin I. Goldstein, David A. Axelson, Michael Strober, Martin Keller, Jeffrey Hunt, Heather Hower, Lauren M. Weinstock, Shirley Yen, Tags: New Research Source Type: research